Meinian Onehealth Healthcare Holdings Co., Ltd.

SZSE:002044 Stock Report

Market Cap: CN¥12.9b

Meinian Onehealth Healthcare Holdings Past Earnings Performance

Past criteria checks 5/6

Meinian Onehealth Healthcare Holdings has been growing earnings at an average annual rate of 18.3%, while the Healthcare industry saw earnings growing at 4.4% annually. Revenues have been growing at an average rate of 6.2% per year. Meinian Onehealth Healthcare Holdings's return on equity is 5%, and it has net margins of 2.7%.

Key information

18.3%

Earnings growth rate

15.1%

EPS growth rate

Healthcare Industry Growth7.0%
Revenue growth rate6.2%
Return on equity5.0%
Net Margin2.7%
Last Earnings Update30 Jun 2024

Recent past performance updates

Recent updates

These 4 Measures Indicate That Meinian Onehealth Healthcare Holdings (SZSE:002044) Is Using Debt Reasonably Well

Jul 28
These 4 Measures Indicate That Meinian Onehealth Healthcare Holdings (SZSE:002044) Is Using Debt Reasonably Well

These Return Metrics Don't Make Meinian Onehealth Healthcare Holdings (SZSE:002044) Look Too Strong

Jul 12
These Return Metrics Don't Make Meinian Onehealth Healthcare Holdings (SZSE:002044) Look Too Strong

Is Meinian Onehealth Healthcare Holdings Co., Ltd. (SZSE:002044) Worth CN¥4.1 Based On Its Intrinsic Value?

Jun 06
Is Meinian Onehealth Healthcare Holdings Co., Ltd. (SZSE:002044) Worth CN¥4.1 Based On Its Intrinsic Value?

Investors Continue Waiting On Sidelines For Meinian Onehealth Healthcare Holdings Co., Ltd. (SZSE:002044)

May 21
Investors Continue Waiting On Sidelines For Meinian Onehealth Healthcare Holdings Co., Ltd. (SZSE:002044)

Is Meinian Onehealth Healthcare Holdings (SZSE:002044) Using Too Much Debt?

Mar 01
Is Meinian Onehealth Healthcare Holdings (SZSE:002044) Using Too Much Debt?

Revenue & Expenses Breakdown

How Meinian Onehealth Healthcare Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SZSE:002044 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 2410,6482853,47862
31 Mar 2410,5783913,35663
31 Dec 2310,8945063,37963
30 Sep 2310,096503,29762
30 Jun 2310,1271133,25960
31 Mar 239,370-2993,17655
01 Jan 238,616-5593,01556
30 Sep 229,144-872,97758
30 Jun 228,771-1792,89158
31 Mar 229,241552,94561
01 Jan 229,216622,90060
30 Sep 219,2638342,89456
30 Jun 219,4099142,90754
31 Mar 218,6507252,82349
31 Dec 207,8485512,62846
30 Sep 206,687-1,7802,46940
30 Jun 206,707-1,6732,42441
31 Mar 207,781-1,3472,55244
31 Dec 198,525-8662,72047
30 Sep 198,9177982,59648
30 Jun 198,5626792,58946
31 Mar 198,5108132,65845
31 Dec 188,4588212,63038
30 Sep 188,0337522,63019
30 Jun 187,5987352,47830
31 Mar 186,7676142,20530
31 Dec 176,2825842,02625
30 Sep 176,4996021,98530
30 Jun 175,4944821,71810
31 Mar 174,7484391,4610
31 Dec 164,3144521,3150
30 Sep 162,6962778560
30 Jun 162,4372747880
31 Mar 162,2212317310
31 Dec 152,1012606770
30 Sep 151,8392096410
31 Dec 141,4311405190
31 Dec 13979343930

Quality Earnings: 002044 has high quality earnings.

Growing Profit Margin: 002044's current net profit margins (2.7%) are higher than last year (1.1%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 002044's earnings have grown by 18.3% per year over the past 5 years.

Accelerating Growth: 002044's earnings growth over the past year (151.3%) exceeds its 5-year average (18.3% per year).

Earnings vs Industry: 002044 earnings growth over the past year (151.3%) exceeded the Healthcare industry -6.3%.


Return on Equity

High ROE: 002044's Return on Equity (5%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies